P

PA Regional Center for Arthritis and Osteoporosis Research | Wyomissing, PA

Research site

Location

1200 BRoadcasting Road, Suite 200, Wyomissing, Pennsylvania, United States of America

Website

https://emkeyarthritis.com/pennsylvania-regional-center-for-arthritis-and-osteoporosis-research/

Site insights

Top conditions

Top treatments

Ixekizumab

Filgotinib

Baricitinib

Tocilizumab

Zasocitinib

methotrexate

Forteo

PF708

acetaminophen

methylprednisolone

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Donna Filippi

Verified by this site

Active trials

3 of 20 total trials

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects the joints and skin in people who have psoriasis (PsO).The main aim of the s...

Enrolling

Psoriatic Arthritis

Drug: Active Comparator

Drug: Zasocitinib

A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)

This is a Phase 2 randomized, double-blind, placebo-controlled study with a total duration of 32 weeks from Screening to End-of-Study (EOS) Visit. Ap...

Enrolling

Active Rheumatoid Arthritis

Drug: ELV001 75 mg

Drug: ELV001 125 mg

Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica

This is a randomized, double-blind, placebo-controlled, parallel-group, Phase 4, 3-group study to assess whether treatment with sarilumab at either 1...

Enrolling

Polymyalgia Rheumatica

Drug: Placebo

Drug: Sarilumab